A detailed history of Flossbach Von Storch Ag transactions in Abbott Laboratories stock. As of the latest transaction made, Flossbach Von Storch Ag holds 8,758,473 shares of ABT stock, worth $1.02 Billion. This represents 3.95% of its overall portfolio holdings.

Number of Shares
8,758,473
Previous 8,466,834 3.44%
Holding current value
$1.02 Billion
Previous $880 Million 13.5%
% of portfolio
3.95%
Previous 3.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$100.07 - $118.13 $29.2 Million - $34.5 Million
291,639 Added 3.44%
8,758,473 $999 Million
Q2 2024

Aug 02, 2024

SELL
$100.73 - $112.44 $10.7 Million - $12 Million
-106,585 Reduced 1.24%
8,466,834 $880 Million
Q1 2024

May 06, 2024

SELL
$109.52 - $120.96 $63.1 Million - $69.7 Million
-576,192 Reduced 6.3%
8,573,419 $974 Million
Q4 2023

Jan 31, 2024

BUY
$90.19 - $110.4 $12.2 Million - $15 Million
135,821 Added 1.51%
9,149,611 $1.01 Billion
Q3 2023

Oct 27, 2023

BUY
$95.53 - $114.62 $70.8 Million - $85 Million
741,441 Added 8.96%
9,013,790 $873 Million
Q2 2023

Aug 02, 2023

BUY
$100.78 - $112.29 $4.18 Million - $4.66 Million
41,485 Added 0.5%
8,272,349 $902 Million
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $39.2 Million - $46.1 Million
404,346 Added 5.17%
8,230,864 $833 Million
Q4 2022

Feb 06, 2023

BUY
$95.06 - $111.52 $42.3 Million - $49.7 Million
445,359 Added 6.03%
7,826,518 $859 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $8.2 Million - $9.49 Million
84,738 Added 1.16%
7,381,159 $714 Million
Q2 2022

Aug 10, 2022

BUY
$102.07 - $123.37 $21.9 Million - $26.5 Million
214,839 Added 3.03%
7,296,421 $793 Million
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $124 Million - $151 Million
1,088,770 Added 18.17%
7,081,582 $838 Million
Q4 2021

Feb 04, 2022

BUY
$115.53 - $141.46 $19.9 Million - $24.3 Million
172,068 Added 2.96%
5,992,812 $843 Million
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $51.8 Million - $57.3 Million
-443,828 Reduced 7.08%
5,820,744 $688 Million
Q2 2021

Aug 02, 2021

BUY
$105.79 - $124.53 $169 Million - $199 Million
1,600,139 Added 34.31%
6,264,572 $726 Million
Q1 2021

May 04, 2021

BUY
$108.84 - $128.23 $9.9 Million - $11.7 Million
90,928 Added 1.99%
4,664,433 $559 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $17.6 Million - $19.2 Million
167,868 Added 3.81%
4,573,505 $501 Million
Q3 2020

Nov 05, 2020

BUY
$91.64 - $111.29 $706,177 - $857,600
7,706 Added 0.18%
4,405,637 $479 Million
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $80.3 Million - $103 Million
-1,048,801 Reduced 19.26%
4,397,931 $402 Million
Q1 2020

May 11, 2020

BUY
$62.82 - $91.86 $135 Million - $197 Million
2,143,839 Added 64.91%
5,446,732 $430 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $10.4 Million - $11.5 Million
131,942 Added 4.16%
3,302,893 $287 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $2.08 Million - $2.26 Million
25,446 Added 0.81%
3,170,951 $265 Million
Q2 2019

Aug 06, 2019

SELL
$72.88 - $85.0 $4.39 Million - $5.12 Million
-60,235 Reduced 1.88%
3,145,505 $265 Million
Q1 2019

May 02, 2019

SELL
$66.22 - $80.06 $140 Million - $169 Million
-2,109,144 Reduced 39.68%
3,205,740 $256 Million
Q4 2018

Feb 05, 2019

SELL
$65.56 - $74.27 $54.8 Million - $62.1 Million
-835,871 Reduced 13.59%
5,314,884 $384 Million
Q3 2018

Nov 05, 2018

SELL
$60.81 - $73.36 $16 Million - $19.3 Million
-263,270 Reduced 4.1%
6,150,755 $451 Million
Q2 2018

Aug 08, 2018

BUY
$57.57 - $63.54 $710,125 - $783,765
12,335 Added 0.19%
6,414,025 $391 Million
Q1 2018

May 04, 2018

SELL
$56.27 - $63.62 $151 Million - $170 Million
-2,678,990 Reduced 29.5%
6,401,690 $384 Million
Q4 2017

Feb 07, 2018

SELL
$53.68 - $57.47 $115 Million - $123 Million
-2,141,329 Reduced 19.08%
9,080,680 $518 Million
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $539 Million - $602 Million
11,222,009
11,222,009 $599 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Flossbach Von Storch Ag Portfolio

Follow Flossbach Von Storch Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

News

Stay updated on Flossbach Von Storch Ag with notifications on news.